Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5092 USD | +7.92% |
|
+1.74% | -51.52% |
05-28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
05-14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 4
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 3 | 100.0 % | 5 | 100.0 % | +106.51% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 5 | 100.0 % | +106.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cam Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Malcolm Hill
BRD | Director/Board Member | 67 | 07-05-31 |
Vickie Reed
BRD | Director/Board Member | 62 | 21-05-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,597,405 | 7,229,373 ( 84.09 %) | 0 | 84.09 % |
Company contact information
Evoke Pharma, Inc.
420 Stevens Avenue Suite 370
92075-2074, Solana Beach
+858 345 1494
http://www.evokepharma.com![address Evoke Pharma, Inc.(EVOK)](https://cdn.zonebourse.com/static/address/14368654.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.52% | 4.06M | |
+52.00% | 823B | |
+39.81% | 641B | |
-6.31% | 352B | |
+16.36% | 324B | |
+7.74% | 301B | |
+13.77% | 241B | |
+1.68% | 223B | |
+13.02% | 218B | |
+7.23% | 167B |
- Stock Market
- Equities
- EVOK Stock
- Company Evoke Pharma, Inc.